These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19699885)

  • 1. Neurohormonal and echocardiographic results after CorCap and mitral annuloplasty for dilated cardiomyopathy.
    Rubino AS; Onorati F; Santarpino G; Pasceri E; Santarpia G; Cristodoro L; Serraino GF; Renzulli A
    Ann Thorac Surg; 2009 Sep; 88(3):719-25. PubMed ID: 19699885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invited commentary.
    Raman J
    Ann Thorac Surg; 2009 Sep; 88(3):726. PubMed ID: 19699886
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitral valve repair in heart failure: five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial.
    Acker MA; Jessup M; Bolling SF; Oh J; Starling RC; Mann DL; Sabbah HN; Shemin R; Kirklin J; Kubo SH
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):569-74, 574.e1. PubMed ID: 21269649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year clinical experience with the Acorn CorCap cardiac support device: results of a limited market release safety study in Italy and Sweden.
    Livi U; Alfieri O; Vitali E; Russo C; Frigerio M; Tursi V; Albanese MC; De Bonis M; Fragasso G; Franco-Cereceda A; Forssell G; Rorke R; Kubo SH
    Ital Heart J; 2005 Jan; 6(1):59-65. PubMed ID: 15773275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
    Feringa HH; Poldermans D; Klein P; Braun J; Klautz RJ; van Domburg RT; van der Laarse A; van der Wall EE; Dion RA; Bax JJ
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy.
    Mann DL; Acker MA; Jessup M; Sabbah HN; Starling RC; Kubo SH;
    Ann Thorac Surg; 2007 Oct; 84(4):1226-35. PubMed ID: 17888974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitral annuloplasty in patients with ischemic versus dilated cardiomyopathy.
    Szalay ZA; Civelek A; Hohe S; Brunner-LaRocca HP; Klövekorn WP; Knez I; Vogt PR; Bauer EP
    Eur J Cardiothorac Surg; 2003 Apr; 23(4):567-72. PubMed ID: 12694777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and functional effects of restrictive mitral annuloplasty at midterm follow-up in heart failure patients.
    ten Brinke EA; Klautz RJ; Tulner SA; Verwey HF; Bax JJ; Delgado V; Holman ER; Schalij MJ; van der Wall EE; Braun J; Versteegh MI; Dion RA; Steendijk P
    Ann Thorac Surg; 2010 Dec; 90(6):1913-20. PubMed ID: 21095335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation.
    Yusoff R; Clayton N; Keevil B; Morris J; Ray S
    Am J Cardiol; 2006 May; 97(10):1498-501. PubMed ID: 16679092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of left ventricular systolic dysfunction on the outcomes of percutaneous edge-to-edge mitral valve repair using MitraClip.
    Kaneko H; Neuss M; Schau T; Weissenborn J; Butter C
    Heart Vessels; 2016 Dec; 31(12):1988-1996. PubMed ID: 26968992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
    Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in serum biomarker profiles after percutaneous mitral valve repair with the MitraClip system.
    Yoon JN; Frangieh AH; Attinger-Toller A; Gruner C; Tanner FC; Taramasso M; Corti R; Lüscher TF; Ruschitzka F; Bettex D; Maisano F; Gaemperli O
    Cardiol J; 2016; 23(4):384-92. PubMed ID: 27296161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation.
    Kainuma S; Taniguchi K; Toda K; Funatsu T; Kondoh H; Nishino M; Daimon T; Sawa Y
    J Thorac Cardiovasc Surg; 2011 Oct; 142(4):783-92. PubMed ID: 21397266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Right Ventricular Dysfunction and Diabetes Mellitus in N-terminal pro-B-type Natriuretic Peptide Response of Patients With Severe Mitral Regurgitation and Heart Failure After MitraClip.
    Kaneko H; Neuss M; Weissenborn J; Butter C
    Int Heart J; 2017 Apr; 58(2):225-231. PubMed ID: 28216549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy.
    Onorati F; Rubino AS; Marturano D; Pasceri E; Santarpino G; Zinzi S; Mascaro G; Renzulli A
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):654-62. PubMed ID: 19698852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac support device, restrictive mitral valve annuloplasty, and optimized medical treatment: a multimodality approach to nonischemic cardiomyopathy.
    Braun J; Ciarka A; Versteegh MI; Delgado V; Boersma E; Verwey HF; Schalij MJ; Bax JJ; Dion RA; van de Veire NR; Klautz RJ
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):e93-100. PubMed ID: 21397275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of clinical, electrocardiographic, echocardiographic and neurohumoral parameters in non-ischaemic dilated cardiomyopathy.
    Tigen K; Karaahmet T; Tanalp AC; Gurel E; Cevik C; Mutlu B; Basaran Y
    Acta Cardiol; 2008 Apr; 63(2):207-12. PubMed ID: 18468202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide response and reverse left ventricular remodeling after surgical correction of functional mitral regurgitation in patients with advanced cardiomyopathy.
    Kainuma S; Taniguchi K; Toda K; Shudo Y; Takeda K; Funatsu T; Miyagawa S; Kondoh H; Nishi H; Yoshikawa Y; Fukushima S; Hamada S; Kubo K; Daimon T; Sawa Y
    J Cardiol; 2015 Oct; 66(4):279-85. PubMed ID: 25851471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restrictive Mitral Annuloplasty With or Without Papillary Muscle Approximation for Functional Mitral Regurgitation.
    Misumi Y; Masai T; Toda K; Nakamura T; Miyagawa S; Yoshikawa Y; Fukushima S; Saito S; Domae K; Kainuma S; Ueno T; Kuratani T; Daimon T; Sawa Y
    J Heart Valve Dis; 2017 Jul; 26(4):447-455. PubMed ID: 29302944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.